Apolipoprotein E phenotypes in familial hypercholesterolaemia: importance for expression of disease and response to therapy
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
To study the possible importance of variation at the apolipoprotein (apo) E gene locus for the clinical expression of heterozygous familial hypercholesterolaemia (FH), we determined apo E phenotype and serum lipoprotein pattern in 120 patients with FH. The allele frequency of the patients studies were: ε 2 0.033, ε 3 0.733, and ε 4 0.233. There was no influence of apo E phenotype on the serum concentrations of total, VLDL, LDL or HDL cholesterol, triglycerides, or of apo AI, B or (a). Serum concentrations of apo E were significantly higher in patients with the apo E 3/3 phenotype compared to those with apo E 4/3 or 4/4, and the highest concentrations were found in patients carrying the ε 2‐allele. The cholesterol‐lowering response to therapy with cholestyramine or pravastatin was not related to apo E phenotype. It is concluded that variation at the apo E gene locus is not of major importance for the expression of heterozygous FH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Apolipoprotein E polymorphism and atherosclerosis.
Davignon, J., Gregg, R. E., & Sing, C. F. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.1.1 · Cited by 1,981
Weisgraber, K. H., Rall, S. C., & Mahley, R. W. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52510-8 · Cited by 777
Zannis, V. I., & Breslow, J. L. (1981) · Biochemistry · doi:10.1021/bi00507a059 · Cited by 563
Utermann, G., Pruin, N., & Steinmetz, A. (1979) · Clinical Genetics · doi:10.1111/j.1399-0004.1979.tb02028.x · Cited by 209
The role of apolipoprotein E genetic variants in lipoprotein disorders.
RALL, S. C., & MAHLEY, R. W. (1992) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1992.tb01254.x · Cited by 150
Utermann, G., Steinmetz, A., & Weber, W. (1982) · Human Genetics · doi:10.1007/bf00569216 · Cited by 149
Demant, T., Bedford, D., Packard, C. J., & Shepherd, J. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115459 · Cited by 145
Eto, M., Watanabe, K., & Ishii, K. (1986) · Clinical Genetics · doi:10.1111/j.1399-0004.1986.tb00547.x · Cited by 112
Genetic variation in human apolipoprotein E
Wardell, M. R., Suckling, P. A., & Janus, E. D. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38055-x · Cited by 89
Apolipoprotein E Mutants, Hyperlipidemia and Arteriosclerosis
Utermann, G. (1985) · Drugs Affecting Lipid Metabolism VIII · doi:10.1007/978-1-4613-2459-1_14 · Cited by 24
Cited by
Tonstad, S., Joakimsen, O., Stensland-Bugge, E., Leren, T. P., Ose, L., Russell, D., & Bønaa, K. H. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.8.984 · Cited by 314
APO E gene and gene-environment effects on plasma lipoprotein-lipid levels
HAGBERG, J. M., WILUND, K. R., & FERRELL, R. E. (2000) · Physiological Genomics · doi:10.1152/physiolgenomics.2000.4.2.101 · Cited by 118
The vascular contribution to Alzheimer's disease
Altman, R., & Rutledge, J. C. (2010) · Clinical Science · doi:10.1042/cs20100094 · Cited by 93
Han, S.-H., Kim, J. S., Lee, Y., Choi, H., Kim, J.-W., Na, D. L., Yang, E. G., Yu, M.-H., Hwang, D., Lee, C., et al. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.028639 · Cited by 29
Metadata
- Authors
- BERGLUND, L., WIKLUND, O., EGGERTSEN, G., OLOFSSON, S. ‐., ERIKSSON, M., LINDÉN, T., BONDJERS, G., & ANGELIN, B.
- Venue
- Journal of Internal Medicine
- Publisher
- Wiley
- Published
- 1993-02
- Volume
- 233
- Issue
- 2
- Pages
- 173-178
- ISSN
- 0954-6820 (ISSN-L)
- 1365-2796
- OpenAlex
- W2077748972
- Cited by
- 49
- References
- 10
- FWCI
- 3.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Apolipoprotein E phenotypes in familial hypercholesterolaemia: importance for expression of disease and response to therapy. https://app.cochat.ai/papers/10.1111/j.1365-2796.1993.tb00670.x
- The paper
- BERGLUND, L., WIKLUND, O., EGGERTSEN, G., OLOFSSON, S. ‐., ERIKSSON, M., LINDÉN, T., BONDJERS, G., & ANGELIN, B. (1993). Apolipoprotein E phenotypes in familial hypercholesterolaemia: importance for expression of disease and response to therapy. Journal of Internal Medicine. https://doi.org/10.1111/j.1365-2796.1993.tb00670.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.